✦ LIBER ✦

Correlation of FCGR3A and EGFR germline polymorphisms with the efficacy of cetuximab in KRAS wild-type metastatic colorectal cancer

✍ Scribed by Jan Pander; Hans Gelderblom; Ninja F. Antonini; Jolien Tol; Johan H.J.M. van Krieken; Tahar van der Straaten; Cornelis J.A. Punt; Henk-Jan Guchelaar

Book ID: 116430365
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 173 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A gene expression predictor of response

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

✍ Justin M Balko; Esther P Black 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 657 KB

EGFR gene gain and PTEN protein expressi

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

✍ Razis, Evangelia; Pentheroudakis, George; Rigakos, George; Bobos, Mattheos; Kouv 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 596 KB

Sensitivity to previous irinotecan treat

Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancer

✍ Kohei Shitara; Takashi Ura; Keitaro Matsuo; Daisuke Takahari; Tomoya Yokota; Sat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Analysis of PTEN, BRAF, and EGFR Status

Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

✍ Laurent-Puig, P.; Cayre, A.; Manceau, G.; Buc, E.; Bachet, J.-B.; Lecomte, T.; R 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 175 KB

Quality of life analysis in patients wit

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

✍ Láng, István; Köhne, Claus-Henning; Folprecht, Gunnar; Rougier, Philippe; Curran 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Economic analysis of bevacizumab, cetuxi

Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB